Inozyme Pharma Appoints Kevin B. Johnson, Ph.D., MBA, as Senior Vice President, Regulatory Affairs by Seini Moimoi | Nov 9, 2020 | Portfolio News
Akebia Reports Third Quarter 2020 Financial Results and Recent Business Updates by Seini Moimoi | Nov 5, 2020 | Portfolio News
Poseida Therapeutics Announces Clinical Hold Lifted on Phase I Autologous CAR-T Study in Prostate Cancer by Seini Moimoi | Nov 2, 2020 | Portfolio News
Kala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease by Seini Moimoi | Oct 27, 2020 | Portfolio News
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option by Seini Moimoi | Oct 26, 2020 | Portfolio News
